ORIC Pharmaceuticals, Inc.ORICNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-113.85M
↓ 102% below average
Average (7y)
$-56.36M
Historical baseline
Range
High:$-21.21M
Low:$-113.85M
CAGR
+27.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-113.85M | -31.6% |
| 2023 | $-86.54M | -12.1% |
| 2022 | $-77.22M | -27.7% |
| 2021 | $-60.48M | -31.7% |
| 2020 | $-45.94M | -89.0% |
| 2019 | $-24.30M | -14.6% |
| 2018 | $-21.21M | +0.5% |
| 2017 | $-21.32M | - |